236 related articles for article (PubMed ID: 12717671)
1. [Nasu Hakola disease: a report of the first two cases in Bolivia].
Molina-Monasterios MC; Molina-Abecia H
Rev Neurol; 2003 May 1-15; 36(9):837-40. PubMed ID: 12717671
[TBL] [Abstract][Full Text] [Related]
2. A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease.
Kuroda R; Satoh J; Yamamura T; Anezaki T; Terada T; Yamazaki K; Obi T; Mizoguchi K
J Neurol Sci; 2007 Jan; 252(1):88-91. PubMed ID: 17125796
[TBL] [Abstract][Full Text] [Related]
3. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
[TBL] [Abstract][Full Text] [Related]
4. Nasu-Hakola disease: a rare entity in Italy. Critical review of the literature.
Montalbetti L; Soragna D; Ratti MT; Bini P; Buscone S; Moglia A
Funct Neurol; 2004; 19(3):171-9. PubMed ID: 15595711
[TBL] [Abstract][Full Text] [Related]
5. C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation.
Solje E; Hartikainen P; Valori M; Vanninen R; Tiihonen J; Hakola P; Tienari PJ; Remes AM
Neurobiol Aging; 2014 Jul; 35(7):1780.e13-7. PubMed ID: 24612676
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial reactions in the spouses of patients suffering polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy.
Hakola HP
J Clin Psychiatry; 1990 Jan; 51(1):21-4. PubMed ID: 2295586
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of microglia in Nasu-Hakola disease brains.
Satoh J; Tabunoki H; Ishida T; Yagishita S; Jinnai K; Futamura N; Kobayashi M; Toyoshima I; Yoshioka T; Enomoto K; Arai N; Arima K
Neuropathology; 2011 Aug; 31(4):363-75. PubMed ID: 21118401
[TBL] [Abstract][Full Text] [Related]
8. Nasu-Hakola disease: The first case reported by Nasu and review: The 50th Anniversary of Japanese Society of Neuropathology.
Kaneko M; Sano K; Nakayama J; Amano N
Neuropathology; 2010 Oct; 30(5):463-70. PubMed ID: 20500450
[TBL] [Abstract][Full Text] [Related]
9. Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.
Sasaki A; Kakita A; Yoshida K; Konno T; Ikeuchi T; Hayashi S; Matsuo H; Shioda K
Neurogenetics; 2015 Oct; 16(4):265-76. PubMed ID: 26001891
[TBL] [Abstract][Full Text] [Related]
10. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages.
Nataf S; Anginot A; Vuaillat C; Malaval L; Fodil N; Chereul E; Langlois JB; Dumontel C; Cavillon G; Confavreux C; Mazzorana M; Vico L; Belin MF; Vivier E; Tomasello E; Jurdic P
Am J Pathol; 2005 Jan; 166(1):275-86. PubMed ID: 15632019
[TBL] [Abstract][Full Text] [Related]
11. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis.
Neumann H; Takahashi K
J Neuroimmunol; 2007 Mar; 184(1-2):92-9. PubMed ID: 17239445
[TBL] [Abstract][Full Text] [Related]
12. Imaging findings of Nasu-Hakola disease: a case report.
Kilic SA; Oner AY; Yuce C; Ozlu IC
Clin Imaging; 2012; 36(6):877-80. PubMed ID: 23154029
[TBL] [Abstract][Full Text] [Related]
13. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature.
Dardiotis E; Siokas V; Pantazi E; Dardioti M; Rikos D; Xiromerisiou G; Markou A; Papadimitriou D; Speletas M; Hadjigeorgiou GM
Neurobiol Aging; 2017 May; 53():194.e13-194.e22. PubMed ID: 28214109
[TBL] [Abstract][Full Text] [Related]
14. DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features.
Paloneva J; Mandelin J; Kiialainen A; Bohling T; Prudlo J; Hakola P; Haltia M; Konttinen YT; Peltonen L
J Exp Med; 2003 Aug; 198(4):669-75. PubMed ID: 12925681
[TBL] [Abstract][Full Text] [Related]
15. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study.
Le Ber I; Camuzat A; Hannequin D; Pasquier F; Guedj E; Rovelet-Lecrux A; Hahn-Barma V; van der Zee J; Clot F; Bakchine S; Puel M; Ghanim M; Lacomblez L; Mikol J; Deramecourt V; Lejeune P; de la Sayette V; Belliard S; Vercelletto M; Meyrignac C; Van Broeckhoven C; Lambert JC; Verpillat P; Campion D; Habert MO; Dubois B; Brice A;
Brain; 2008 Mar; 131(Pt 3):732-46. PubMed ID: 18245784
[TBL] [Abstract][Full Text] [Related]
16. CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts.
Paloneva J; Autti T; Raininko R; Partanen J; Salonen O; Puranen M; Hakola P; Haltia M
Neurology; 2001 Jun; 56(11):1552-8. PubMed ID: 11402114
[TBL] [Abstract][Full Text] [Related]
17. [Molecular Pathogenesis of Nasu-Hakola Disease Brain Lesions].
Satoh J
Brain Nerve; 2016 May; 68(5):543-50. PubMed ID: 27156507
[TBL] [Abstract][Full Text] [Related]
18. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts.
Paloneva J; Kestilä M; Wu J; Salminen A; Böhling T; Ruotsalainen V; Hakola P; Bakker AB; Phillips JH; Pekkarinen P; Lanier LL; Timonen T; Peltonen L
Nat Genet; 2000 Jul; 25(3):357-61. PubMed ID: 10888890
[TBL] [Abstract][Full Text] [Related]
19. Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS.
Kiialainen A; Hovanes K; Paloneva J; Kopra O; Peltonen L
Neurobiol Dis; 2005 Mar; 18(2):314-22. PubMed ID: 15686960
[TBL] [Abstract][Full Text] [Related]
20. Nasu-Hakola disease (polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy--PLOSL): a dementia associated with bone cystic lesions. From clinical to genetic and molecular aspects.
Bianchin MM; Capella HM; Chaves DL; Steindel M; Grisard EC; Ganev GG; da Silva Júnior JP; Neto Evaldo S; Poffo MA; Walz R; Carlotti Júnior CG; Sakamoto AC
Cell Mol Neurobiol; 2004 Feb; 24(1):1-24. PubMed ID: 15049507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
